Navigation Links
William E. Lewandowski to Lead Simbionix US Marketing Team in Simbionix's Strategic Expansion in the US Market
Date:11/3/2008

CLEVELAND, Ohio and LOD, Israel, November 3 /PRNewswire/ -- Simbionix USA Corporation (Simbionix), a developer of medical simulators and hands-on curriculum for training medical professionals, today announced that William E. Lewandowski will join the company as the US Marketing Director on November 10th, 2008. Gary Zamler, Simbionix CEO stated, "Over the past two consecutive years, Simbionix has enjoyed double digit revenue growth in both our International and Domestic markets. We are particularly pleased to have someone of Bill's caliber join our expanding US organization to increase the momentum as we rollout new and exciting products such as 'PROcedure Rehearsal Studio' the Simulation Industry's first patient specific technology."

Bill brings to Simbionix a unique background with over 20 years of experience in the business of training and simulation in the aviation, defense and medical industries. For the last 3 years, Bill has been an independent consultant in the acquisition, development, use and validation of simulation and training devices to a wide range of clients in Asia, Europe, and the United States . Inbal Mazor, Simbionix Corporate VP Marketing stated, " Bill's experience and knowledge will assist us to maintain our market leadership position within the medical education and simulation markets. We are pleased to have Bill join Simbionix and lead our US marketing efforts."

In addition to his consultant work, Bill has held key positions in the training and simulation industry. Bill held the position of Vice President for Simulation Systems, and later Business Development, for a producer of medical simulations. He oversaw the development of medical simulation products and established development contracts with leading medical device companies. At FlightSafety International (a major international producer of flight simulators and commercial aviation training), Bill managed a division that developed Federal Aviation Administration (FAA) certified training products, which included instructor-led courseware, eLearning, and non-motion simulations. He was also instrumental in winning curriculum development contracts with major airplane manufacturers in Brazil , Canada , France , Israel , and the United States .

Bill rounds out his business experience with solid academic credentials. He holds a Master of Science (MS) degree in Instructional and Performance Technology from Boise State University , Idaho , and he is currently pursuing a research Doctor of Philosophy (PhD) degree in Health Science at the University of Liverpool, UK. He has published and presented in professional medical society venues and has served on publication peer review committees for instructional design and medical societies. Bill is a member of the American Society for Training and Development, the International Society for Performance Improvement and the Society for Simulation in Healthcare.

Contact:

Gary Zamler,

CEO,

Simbionix, USA Corporation,,

Tel: +1-216-229-2040,

Fax: +1-216-229-2070,

Email: gary@simbionix.com .


'/>"/>
SOURCE Simbionix Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Nutrition 21 Appoints Pam McWilliams, Vice President - General Manager of Direct Response
2. PAREXEL International to Present at William Blair Small-Cap Growth Stock Conference
3. Verenium Corporation to Present at the William Blair & Company 2008 Small-Cap Growth Stock Conference
4. Anesiva Announces Appointment of William Houghton, M.D. as Senior Vice President and Chief Medical Officer
5. ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
6. William F. Prendergast Named One of the Top IP Lawyers in Nanotechnology
7. ArunA Biomedical Names William T. Sharp President and Chief Executive Officer
8. Portola Pharmaceuticals Names William Lis Vice President of Business Development and Commercial Operations
9. William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
10. Gen-Probe to Webcast Presentation at the William Blair & Company 28th Annual Growth Stock Conference
11. Alexion to Present at the William Blair 28th Annual Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , ... June 24, 2016 , ... Researchers at the ... commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the subject ... it now. , Diagnostic biomarkers are signposts in the blood, lung fluid or ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... to announce the launch of their brand, UP4™ Probiotics, into Target stores nationwide. ... years, is proud to add Target to its list of well-respected retailers. This ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... HOUSTON , June 23, 2016 ... agreement with the Cy-Fair Sports Association to serve ... of the agreement, Houston Methodist Willowbrook will provide ... education and connectivity with association coaches, volunteers, athletes ... partner with the Cy-Fair Sports Association and to ...
Breaking Biology Technology:
(Date:6/9/2016)... , June 9, 2016 ... deploy Teleste,s video security solution to ensure the safety of ... during the major tournament Teleste, an ... systems and services, announced today that its video security solution ... to back up public safety across the country. The ...
(Date:6/2/2016)... June 2, 2016 Perimeter Surveillance ... Unmanned Systems, Physical Infrastructure, Support & Other Service  ... visiongain offers comprehensive analysis of the global ... will generate revenues of $17.98 billion in 2016. ... Inc, a leader in software and hardware technologies for ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
Breaking Biology News(10 mins):